About Nobel Biocare
Nobel Biocare is a Healthcare company based in Zurich (Switzerland) founded in 1952, and was acquired by Danaher in September 2014. Implant, prosthetic and regenerative solutions for dental markets. The company has 2,398 employees. Nobel Biocare has completed 3 acquisitions, including Alpha-Bio Tec, BioCad Medical and Steri-OSS. Its website nobelbiocare.com draws about 157 thousand monthly visits. Its Indian entity Nobel Biocare India Private Limited reported revenue of ₹175 Cr. Its focus areas include Life Sciences, Dental Disorders, Medical Devices and Therapeutic Devices.
Company details
Nobel Biocare, a part of Danaher Corporation, focusses on implant-based dental restorations. The companys portfolio offers solutions dental implant systems (with indications from single-tooth to fully edentulous), prosthetics and CADCAM systems, diagnostics, treatment planning and guided surgery solutions and biomaterials. The company provides training and education along with practice support and patient information materials. The production sites are in the United States, Sweden, Japan, and Israel; The products and services are available in over 80 countries through subsidiaries and distributors.
- Headquarters Zurich, Switzerland
- Employees 2,398
- Stage Acquired
- SectorsHealthcare
- Website category Health
- Email••••••••
- Phone•••• ••••
- Website nobelbiocare.com/en-int
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Danaher (Sep 2014)
- Legal Name Nobel Biocare India Private Limited
- Date of Incorporation 29 Dec, 2004
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹175 Cr
FY 2026 · +10% YoY
- Indian entity net profit₹7.75 Cr
FY 2026 · 4% margin
- Indian entity EBITDA₹11.03 Cr
FY 2026 · 6% margin
- Investors
- Employee Count2,398
- Investments & AcquisitionsAlpha-Bio Tec
& 2 more
- Acquired byDanaher
(Sep 2014)
Associated legal entities of Nobel Biocare
Nobel Biocare operates through Nobel Biocare India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nobel Biocare India Private Limited CIN U51397MH2004FTC150267 | Active | 29 Dec 2004 | Mumbai, Maharashtra | ₹175 Cr | 79 | 2 | View details |
Apps and channels of Nobel Biocare
its YouTube channel Nobel Biocare has 152K subscribers and 30 videos.
Videos from Nobel Biocare
The most watched videos on Nobel Biocare's YouTube channel, Nobel Biocare (152K subscribers). Click a video to play it here.
More on Nobel Biocare.
Investors in Nobel Biocare
Nobel Biocare has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Danaher.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dental equipment and medical instruments are manufactured for therapeutic areas. | 1969 | danaher.com |
Investor details for Nobel Biocare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Nobel Biocare India Private Limited (Nobel Biocare)
Nobel Biocare India Private Limited is the primary company behind Nobel Biocare. The board of Nobel Biocare India Private Limited currently have 2 directors; the longest-serving is Tanmay Goyal, appointed in 2019. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tanmay Goyal DIN 08573501 | Director | 26 Sep 2019 | 7 yrs 1 mo | Nobel Biocare India Private Limited |
| Vikrant Subhash Trilokekar DIN 06962369 | Managing Director | 14 Jan 2026 | 10 mo | Nobel Biocare India Private Limited |
People of Nobel Biocare
777 people are tracked at Nobel Biocare (385 in leadership, 20 in board & advisors, 372 in team); the tracked headcount is 2,398.
| Name | Role | Group |
|---|---|---|
Deepu Joseph | Director Talent Acquisition, Sea, Hong Kong & Taiwan | Leadership |
Rosina Palmer | Director Of Strategic Development | Leadership |
Maria Lopez | Vice President, Human Resources, Product Identification Platform | Leadership |
Hannah Kohrs | General Manager Development Program (gmdp) | Leadership |
Amit Agrawal | Chief Scientific Officer, Diagnostics Platform | Leadership |
Hiroyasu Suzuki | Director, DBS Office Lean | Leadership |
Carrie Uhl | Chief Procurement Officer | Leadership |
Paulo Goffi | Latin America & Caribbean HR & EHS Director | Leadership |
Diane Hartwick | Vice President Human Resources, Latin America | Leadership |
Chelsea Creech | General Manager Development Program (gmdp) | Leadership |
Matt Hicks | Director, Talent Acquisition | Leadership |
Scott Levin | Vice President, Clinical Science & Evidence Generation At Danaher Diagnostics | Leadership |
David Pratt | DBSO Director, Lean | Leadership |
Sofia Piquero Monge | Senior Talent Acquisition Partner South Europe | Leadership |
Craig S. | Vice President, HR Operations & Insights | Leadership |
An Yee Angelina Cho | General Manager Development Program | Leadership |
Rikke Flindt Bergstedt | Vice President, Danaher Human Resources Europe | Leadership |
Matt McGrew | EVP, CFO | Leadership |
Laura Butler | Sr. Director, Executive Talent Planning | Leadership |
Patricia Ritter | DBSO Senior Director Lean, Danaher Reliability Systems | Leadership |
757 more people are available in the full profile.
Complete people profiles for Nobel Biocare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Nobel Biocare
Figures of Nobel Biocare India Private Limited, the primary company behind Nobel Biocare, for FY 2026. Revenue was ₹175 Cr (+10% year on year). Net profit was ₹7.75 Cr (4% margin). EBITDA was ₹11.03 Cr (6% margin). Revenue has grown at a compounded annual rate of +12% over three years and +13% over five years.
- ₹175 CrRevenue · FY 2026 · +10% YoY
- ₹7.75 CrNet profit · 4% margin
- ₹11.03 CrEBITDA · 6% margin
- ₹3.2 LakhPaid-up capital
- 79Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nobel Biocare India Private Limited are on its company page.
Detailed financial statements for Nobel Biocare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nobel Biocare
Nobel Biocare has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Alpha-Bio Tec, BioCad Medical and Steri-OSS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of domain registration and web hosting services | biocad.ca | Quebec, Canada | 2006 | Nov 2008 | $33.74M | |
Dental implants and prosthetic solutions are manufactured. | alpha-bio.net | Kiryat Gat, Israel | 1988 | Feb 2008 | $95M | |
Steri-Oss designs, manufactures and markets dental implants and prosthetic components used in tooth replacement. | steri-oss.com | Yorba Linda, United States | 1985 | Jun 1999 | •••• |
Complete acquisition details for Nobel Biocare
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Nobel Biocare
6 dated milestones of Nobel Biocare across 62 years, from founding to its latest funding, stage changes and deals.
- Founded Nobel Biocare is founded.
- Acquisition Acquires Steri-OSS.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Alpha-Bio Tec.
- Acquisition Acquires BioCad Medical.
- Exit Acquired by Danaher.
Web traffic of Nobel Biocare
The website of Nobel Biocare (nobelbiocare.com) receives about 156.6K visits a month and ranks #200,145 among all websites worldwide, #6,490 in Health.
- Monthly visits156.6K
▼ 15.1% vs previous month
- Unique visitors74.4K
per month
- Global rank#200,145
among all websites
- Category rank#6,490
Health · Health
- Bounce rate42%
- Pages per visit3.5
- Average visit1 min 56 sec
- DevicesDesktop 43% · Mobile 57%
Websites whose visitors overlap most with Nobel Biocare. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dentsplyimplants.com | 100% | View details | |||
| implantdirect.com | 92% | #507,588 | View details | ||
shop.benco.com | shop.benco.com | 91% | #315,865 | – | |
| sterngold.com | 87% | #2,975,937 | View details | ||
cosmedent.com | cosmedent.com | 87% | #1,466,722 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Nobel Biocare
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nobel Biocare
Complete news archive for Nobel Biocare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nobel Biocare
Nobel Biocare was founded in 1952.
Nobel Biocare is headquartered in Zurich, Switzerland.
Nobel Biocare has 2,398 employees.
The primary company behind Nobel Biocare, Nobel Biocare India Private Limited, reported revenue of ₹175 Cr for FY 2026, up 10% year on year.
Nobel Biocare, a part of Danaher Corporation, focusses on implant-based dental restorations. The companys portfolio offers solutions dental implant systems (with indications from single-tooth to fully edentulous), prosthetics and CADCAM systems, diagnostics, treatment planning and guided surgery solutions and biomaterials. The company provides training and education along with practice support and patient information materials. The production sites are in the United States, Sweden, Japan, and Israel; The products and services are available in over 80 countries through subsidiaries and distributors.
Nobel Biocare has made 3 acquisitions, including Alpha-Bio Tec, BioCad Medical, and Steri-OSS.
Nobel Biocare has 1 investor. Key investors include Danaher.
Nobel Biocare operates through Nobel Biocare India Private Limited.
Yes. Nobel Biocare was acquired by Danaher in September 2014.
The legal entities of Nobel Biocare currently have 2 directors, including Tanmay Goyal, Vikrant Subhash Trilokekar.
The website of Nobel Biocare receives about 157 thousand visits a month and ranks #200,145 among all websites worldwide.

